Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 1.13 USD -3.42% Market Closed
Market Cap: 39.1m USD

Intrinsic Value

ITRM doesn't have a meaningful market cap.

The intrinsic value of one ITRM stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.13 USD, Iterum Therapeutics PLC is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ITRM Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Iterum Therapeutics PLC

ITRM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ITRM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ITRM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Iterum Therapeutics PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Iterum Therapeutics PLC

Current Assets 24.8m
Cash & Short-Term Investments 24.1m
Receivables 48k
Other Current Assets 614k
Non-Current Assets 19.8m
PP&E 23k
Intangibles 19.7m
Other Non-Current Assets 39k
Efficiency

Free Cash Flow Analysis
Iterum Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Iterum Therapeutics PLC

Revenue
0 USD
Cost of Revenue
-254k USD
Gross Profit
-254k USD
Operating Expenses
-18.4m USD
Operating Income
-18.7m USD
Other Expenses
-6.1m USD
Net Income
-24.8m USD
Fundamental Scores

ITRM Profitability Score
Profitability Due Diligence

Iterum Therapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Iterum Therapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ITRM Solvency Score
Solvency Due Diligence

Iterum Therapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Iterum Therapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ITRM Price Targets Summary
Iterum Therapeutics PLC

Wall Street analysts forecast ITRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITRM is 7.65 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
347% Upside
Average
Price Target
7.65 USD
577% Upside
Highest
Price Target
10.5 USD
829% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Iterum Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for ITRM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

ITRM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ITRM stock?

The intrinsic value of one ITRM stock under the Base Case scenario is hidden USD.

Is ITRM stock undervalued or overvalued?

Compared to the current market price of 1.13 USD, Iterum Therapeutics PLC is hidden .

Back to Top